Coherus Oncology (CHRS) Return on Assets [ROA] (2014 - 2026)
Coherus Oncology's Return on Assets [ROA] was -57.80% in Q2 2026, down 102.15 percentage points from 44.35% a year earlier and down 128.84 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Coherus Oncology came in at 47.54%, up 42.25 percentage points from FY2024.
- Return on Assets [ROA] has now increased for three consecutive years, with a five-year change of +26.39 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was 5.29% in FY2024 (+48.13 pp), -42.85% in FY2023 (+7.45 pp), -50.29% in FY2022 (-12.54 pp) and -37.75% in FY2021 (-58.90 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q2 2023.
- Compared with a year earlier, Return on Assets [ROA] was higher in six of the last eight quarters, with an average year-over-year change of +22.76 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2026 (a gain of 103.00 percentage points); the worst was Q2 2026 (a drop of 102.15 percentage points).
- Per Business Quant data, CHRS's Return on Assets [ROA] in the three quarters before Q2 2026 was 71.04% (Q1 2026), 43.37% (Q4 2025) and 32.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.28 Bn | 1,194.89 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 653.62 Bn | 573.48 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 509.01 Bn | 477.02 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 362.31 Bn | 325.26 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 312.49 Bn | 285.73 Bn | - | - |
| 6 | Astrazeneca | 285.84 Bn | 259.73 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 248.19 Bn | 199.85 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 208.17 Bn | 183.27 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 166.64 Bn | 114.00 Bn | 12.56 Bn | 2.00% |
| 10 | Coherus Oncology | 116.82 Mn | -519.32 Mn | 10.07 Mn | -57.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.80% |
| Mar 31, 2026 | 71.04% |
| Dec 31, 2025 | 43.37% |
| Sep 30, 2025 | 32.42% |
| Jun 30, 2025 | 44.35% |
| Mar 31, 2025 | -31.95% |
| Dec 31, 2024 | 5.98% |
| Sep 30, 2024 | -0.08% |
| Jun 30, 2024 | -4.08% |
| Mar 31, 2024 | -8.51% |
| Dec 31, 2023 | -39.21% |
| Sep 30, 2023 | -41.22% |
| Jun 30, 2023 | -60.58% |
| Mar 31, 2023 | -61.45% |
| Dec 31, 2022 | -56.55% |
| Sep 30, 2022 | -50.80% |
| Jun 30, 2022 | -40.46% |
| Mar 31, 2022 | -33.04% |
| Dec 31, 2021 | -40.41% |
| Sep 30, 2021 | -31.28% |
API Access
Coherus Oncology Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();